Subhabrata Chakrabarti Selected Research

neurotrophin 4

1/2011	Complex genetic mechanisms in glaucoma: an overview.
10/2010	Variations in NTF4, VAV2, and VAV3 genes are not involved with primary open-angle and primary angle-closure glaucomas in an indian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Subhabrata Chakrabarti Research Topics

Disease

6	Glaucoma 01/2017 - 09/2004
5	Macular Degeneration (Age-Related Maculopathy) 09/2012 - 09/2006
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 10/2014
4	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2018 - 02/2005
3	Keratitis 06/2021 - 07/2012
3	Inflammation (Inflammations) 01/2021 - 07/2007
2	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021 - 01/2019
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2019 - 01/2004
2	Type 2 Diabetes Mellitus (MODY) 10/2014 - 09/2009
1	Choroidal Neovascularization 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Leber Congenital Amaurosis 01/2019
1	Ciliopathies 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Cataract (Cataracts) 01/2017
1	Disease Progression 01/2017
1	Familial Exudative Vitreoretinopathies 06/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2014
1	Self Mutilation 10/2014
1	Melanoma (Melanoma, Malignant) 07/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2009
1	Dyskinesias (Dyskinesia) 01/2004
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2004
1	Parkinsonian Disorders (Parkinsonism) 01/2004
1	Ataxia (Dyssynergia) 01/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2006
4	Complement System Proteins (Complement)IBA 01/2021 - 01/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2017
3	Retinaldehyde (Retinal)IBA 01/2021 - 01/2019
2	CytokinesIBA 01/2017 - 07/2012
2	Transcription Factors (Transcription Factor)IBA 07/2014 - 01/2009
2	Toll-Like Receptor 4IBA 10/2012 - 09/2006
2	Complement Factor B (Factor B)IBA 09/2012 - 01/2010
2	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2011 - 02/2005
2	neurotrophin 4IBA 01/2011 - 10/2010
2	Complement Factor H (Factor H)IBA 07/2007 - 09/2006
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2021
1	Edetic Acid (EDTA)FDA Link 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Long Noncoding RNAIBA 01/2021
1	ThrombospondinsIBA 01/2021
1	CalciumIBA 01/2019
1	cytoplasmic protein A (PACD)IBA 11/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2017
1	AngiopoietinsIBA 01/2017
1	CateninsIBA 06/2016
1	LigandsIBA 06/2016
1	AdiponectinIBA 10/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2014
1	Microphthalmia-Associated Transcription FactorIBA 07/2014
1	DefensinsIBA 10/2012
1	Complement C2 (Complement Component 2)IBA 09/2012
1	Interleukin-6 (Interleukin 6)IBA 07/2012
1	Interleukin-12 (IL 12)IBA 07/2012
1	InterleukinsIBA 07/2012
1	Complement C3 (C3 Complement)IBA 06/2011
1	ResistinIBA 09/2009
1	PPAR gammaIBA 09/2009
1	Histidine (L-Histidine)FDA Link 07/2007
1	Tyrosine (L-Tyrosine)FDA Link 07/2007
1	human CYP1B1 proteinIBA 12/2006
1	Apolipoproteins E (ApoE)IBA 09/2006
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2004
1	Dihydroxyphenylalanine (Dopa)IBA 01/2004
1	Levodopa (L Dopa)FDA LinkGeneric 01/2004

Therapy/Procedure

2	Contact Lenses 10/2012 - 07/2012
1	Therapeutics 01/2019
1	Anesthesia 10/2014